Orthopaedic Implants Worth Rs 70L Seized By FDA

Nagpur: The Food and Drug Administration (FDA) team seized orthopaedic implants worth around Rs 70 lakh from a stockist during a raid at Dhantoli last week. The implants, mostly imported, were stocked without licences.

The team, under supervision of FDA joint commissioner (drug), Viraj Paunikar, served a notice to the stockist to furnish bills and invoices within three days.

The team comprising drug inspectors Neeraj Lohkare, Prashant Ramteke, Manish Chaudhuri and Shehnaz Taji acted on a tip-off and took action.

“If the stockist provides us bills and invoices, only then the seized materials would be considered legally procured items, else there he would be prosecuted for the irregularity,” said an official adding most of the seized implants were meant to be sent to different private hospitals.

Related Posts

  • Pharma
  • June 18, 2025
  • 91 views
Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

  • Pharma
  • June 18, 2025
  • 80 views
ED conducts searches across six States in drug trafficking case

The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda